A fulminant colitis index greater or equal to 8 is not predictive of colectomy risk in infliximab-treated moderate-to-severe ulcerative colitis attacks. [electronic resource]
- Gastroenterologie clinique et biologique Nov 2010
- 612-7 p. digital
Publication Type: Journal Article
0399-8320
10.1016/j.gcb.2010.07.013 doi
Adolescent Adult Aged Anti-Inflammatory Agents--therapeutic use Antibodies, Monoclonal--therapeutic use Colectomy--methods Colitis, Ulcerative--diagnosis Drug Therapy, Combination Female Gastrointestinal Agents--therapeutic use Glucocorticoids--therapeutic use Humans Infliximab Intestinal Mucosa--pathology Male Middle Aged Predictive Value of Tests Retrospective Studies Risk Assessment Risk Factors Sensitivity and Specificity Severity of Illness Index Treatment Outcome